Showing 3011-3020 of 3223 results for "".
- MIGS Devices Continue to Expand Use of Glaucoma Surgeryhttps://modernod.com/news/migs-devices-continue-to-expand-use-of-glaucoma-surgery/2476811/Minimally invasive glaucoma surgery (MIGS) stents account for nearly half of all glaucoma surgical device revenue in 2019, according to a Market Scope report. Market penetration of these stents over the past 5 years has been impressive, but the voluntary recall of the Alcon CyPass in 2018
- Rare Complication of Eye Surgery Can Kill in a Minutehttps://modernod.com/news/rare-complication-of-eye-surgery-can-kill-in-a-minute/2476790/Ocular venous air embolism, a very rare complication of vitrectomy, is almost always fatal, yet some retina specialists have not heard of it, according to a Medscape report. The complication can kill in less than a minute, said Rob
- Forbes: Will Your iPhone’s Dark Mode Save Your Eyes?https://modernod.com/news/forbes-will-your-iphones-dark-mode-save-your-eyes/2476786/Eye care has come a long way. From cataract surgery to Lasik, we can do more than ever before to return sight to those who once would have lost it. These days, it seems like there’s always a new breakthrough around the corner—here’s a roundup of some of the biggest trends in eye care and what the
- Okayama University Research: Prosthetics for Retinal Stimulationhttps://modernod.com/news/okayama-university-research-prosthetics-for-retinal-stimulation/2476774/In a study recently published in Advanced Biomedical Engineering, researchers at Okayama University in Japan report a thin photoelectric film which can stimulate degenerated retinal tissues of the eye. Using electric signals to stimulate tissues is the basis of several medical devic
- Pfizer to Combine Upjohn Off-Patent Drug Business With Mylan Into New Companyhttps://modernod.com/news/pfizer-to-combine-upjohn-off-patent-drug-business-with-mylan-into-new-company/2476776/Pfizer plans to combine its Upjohn off-patent branded and generic established medicines business with Mylan into a new company, the drugmakers announced Monday, confirming a recent report on the matter. Under the all-stock transaction, which has been unanimously approved by the boards of both com
- New Software Update Expands Capabilities of the OD-OS Navilas 577shttps://modernod.com/news/new-software-update-expands-capabilities-of-the-od-os-navilas-577s/2476754/OD-OS has released a new software update for its Navilas 577s. With a new multimodal “export wizard,” retina specialists can generate high resolution images of their treatments in different configurations. This allows for advanced, transparent documentation for all purposes and record
- Eye Specialist Works to Prevent Motor Vehicle Related Traumatic Eye Injurieshttps://modernod.com/news/eye-specialist-works-to-prevent-motor-vehicle-related-traumatic-eye-injuries/2476751/Within a 6-week period, Grady Memorial Hospital eye specialist Yousuf Khalifa, MD, witnessed an unusual set of traumatic eye injuries. Three patients, all riding with their windows down, suffered serious eye injuries when the glass in their exterior rear-facing side
- Sun Pharma Introduces Access Program for Patients Prescribed Xelpros in the UShttps://modernod.com/news/sun-pharma-introduces-access-program-for-patients-prescribed-xelpros-in-the-us/2476741/Sun Ophthalmics has launched Xelpros Xpress, an access program for patients prescribed Xelpros (latanoprost ophthalmic emulsion) 0.005%. Xelpros recently became commercially available in the United States for the reduction of elevated IOP in people with open-angle glaucoma or ocular hypertension.
- Medicel Launches First 2-in-1 Lens Injection Systemhttps://modernod.com/news/medicel-launches-first-2-in-1-lens-injection-system/2476740/Medicel says it has launched the world’s first 100% 2-in-1 lens injector, the Accuject Dual. The new injector enables surgeons to operate either in push or screw mode, allowing more control. Unlike competitor dual-mode injectors on the market that are 50% push and 50% screw, the Accuject
- Any Microvascular Disease a Risk Factor for Limb Amputationhttps://modernod.com/news/any-microvascular-disease-a-risk-factor-for-limb-amputation/2476728/The presence of microvascular disease, even in the kidneys or eyes, sharply raises the risk of lower-extremity amputation, and more so in patients who also have peripheral artery disease (PAD), suggests a new analysis of more than 125,600 mostly male participants in the Veterans Aging Cohort Stud